Nuclear medicine and radiation therapy firm ADAC Laboratories has received Food and Drug Administration 510(k) clearance for its P3IMRT intensity modulated radiation therapy (IMRT) inverse planning software. P3IMRT will be deployed with the Milpitas, CA-based firm’s Pinnacle3 radiation therapy planning product.
By AuntMinnie.com staff writersFebruary 12, 2001
Related Reading
Philips to re-enter nuclear medicine market with bid to buy ADAC, November 13, 2000
Copyright © 2001 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
